Ken Fisher
ONC

Ken Fisher’s BeOne Medicines Ltd ONC Stock Holding History

Ken Fisher’s Portfolio ONC Stock Details ONC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-2,126
Closed -$379K – 1269
2023
Q2 		$379K Buy
2,126
+181
+9% +$41.7K ﹤0.01% 906
2023
Q1 		$419K Buy
1,945
+320
+20% +$76.8K ﹤0.01% 871
2022
Q4 		$357K Buy
1,625
+1
+0.1% +$183 ﹤0.01% 889
2022
Q3 		$219K Sell
1,624
-1,725
-52% -$296K ﹤0.01% 873
2022
Q2 		$542K Buy
3,349
+2
+0.1% +$312 ﹤0.01% 705
2022
Q1 		$631K Sell
3,347
-55
-2% -$11.7K ﹤0.01% 695
2021
Q4 		$922K Sell
3,402
-397
-10% -$134K ﹤0.01% 659
2021
Q3 		$1.38M Sell
3,799
-135
-3% -$44.1K ﹤0.01% 570
2021
Q2 		$1.35M Buy
3,934
+2,318
+143% +$768K ﹤0.01% 573
2021
Q1 		$562K Buy
1,616
+1
+0.1% +$331 ﹤0.01% 689
2020
Q4 		$417K Buy
+1,615
New +$445K ﹤0.01% 738

Other funds holding ONC

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
CII
Capital International Inc Los Angeles, California $13B AUM 31.88% 1-Year Est. Return

Ken Fisher's ONC Position: Q3 2023 in Review

Ken Fisher sold out of BeOne Medicines Ltd (ONC) in Q3 2023, closing a stake of 2,126 shares — an estimated $379K sold.

Ken Fisher first reported a position in ONC in Q4 2020 and held it in 11 quarters. The position peaked at $1.38M in Q3 2021. 201 funds tracked by Wall St. Rank hold ONC as of Q3 2023.

  • Ken Fisher reported no remaining BeOne Medicines Ltd position as of Q3 2023 after selling out during the quarter.
  • Ken Fisher sold 2,126 BeOne Medicines Ltd shares in Q3 2023, an estimated $379K.
  • Ken Fisher first reported a position in BeOne Medicines Ltd in Q4 2020 and held it in 11 quarters.
  • Ken Fisher's BeOne Medicines Ltd position peaked at $1.38M in Q3 2021.
  • 201 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q3 2023.

Based on Fisher Asset Management's 13F filing for Q3 2023, filed 13 Nov 2023.